As of January 22, 2025, Tiziana Life Sciences (TLSA) has a market cap of $82.737 million USD. According to our data, Tiziana Life Sciences is ranked No.7835 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $82.74 M |
13.84%
|
Dec 31, 2024 | $72.68 M |
25.00%
|
Dec 29, 2023 | $58.14 M |
-6.67%
|
Dec 30, 2022 | $62.29 M |
-37.50%
|
Dec 31, 2021 | $99.67 M |
-52.48%
|
Dec 31, 2020 | $0.21 B |
86.96%
|
Dec 31, 2019 | $0.11 B |
-27.52%
|
Dec 31, 2018 | $0.15 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Market Cap | = | TLSA Stock Price | * | TLSA Shares Outstanding |
= | $0.80 | * | 0.10 B | |
= | $82.74 M |